ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2016

Abstract Number: 3018

The Analysis of Severity of Arthritis in the Intestinal Microbiota-Humanized Mice

Yuichi Maeda1, Masato Matsushita2, Masashi Narazaki3, Yukihiko Saeki4,5, Atsushi Kumanogoh6 and Kiyoshi Takeda7, 1Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, 2Rheumatology, Osaka Minami Medical Center, Osaka, Japan, 3Osaka University Graduate School of Medicine, Suita, Japan, 4Dept of Clinical research, Osaka-Minami Medical Ctr, Osaka, Japan, 5Dept of Clinical Research, Osaka-Minami Medical Center, Kawachinagano City, Japan, 6Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Suita, Japan, 7Department of Microbiology and Immunology, Osaka University Graduate School of Medicine, Suita, Japan

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: Animal models, microbiome and rheumatoid arthritis (RA)

Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Although various genetic factors have been implicated in susceptibility to rheumatoid arthritis (RA), environmental factors including smoking, periodontal disease and hormones are also necessary for the disease manifestations. We speculate that gut microbiota is one such environmental factor that may be correlated with the development of RA. Previous reports have demonstrated that RA patients have altered composition of gut microbiota. However, it remains unclear whether the altered composition of intestinal microbiota observed in RA patients causes the disease onset.

Methods: We first examined whether RA patients have particular patterns of microbiota. All the patients were diagnosed according to the American College of Rheumatology/European League Against Rheumatism 2010 classification criteria for RA. We collected human fecal samples from 17 untreated new-onset RA patients (disease duration 1.0±0.7 years, mean±SD) and 13 healthy volunteers to investigate the microbiota by 16S rRNA-based deep sequence technique. We further analyzed the correlation between bacterial counts of intestinal microbiota and disease activity in 50 treated RA patients (disease duration 9.6±9.0 years, mean±SD) by quantitative reverse transcription PCR (RT-qPCR) method. We also inoculated human fecal samples from new-onset RA patients or healthy controls into germ free SKG mice (intestinal microbiota-humanized mice) and analyzed for the severity of arthritis and immune responses. We next evaluated whether Prevotella copri (P. copri) has an ability to induce Th17-related cytokines in vitro. Bone marrow-derived DCs were stimulated with intestinal bacteria and analyzed for the production of Th17-related cytokines. Finally, we inoculated P. copri into germ free SKG mice and analyzed severity of arthritis.

Results: Six out of 17 new-onset RA patients showed high abundance of Prevotella. Especially, P. copri was dominant OTU in the RA patients. None of the healthy controls harbored increased abundance of Prevotella. The bacterial counts of Prevotella were positively correlated with the disease activity of treated 50 RA patients (r = 0.36, P<0.01). SKG mice harboring Prevotella-dominated microbiota from new-onset RA patients (RA-SKG mice) showed severe arthritis in the presence of zymosan injection. Increased number of Th17 cells in the regional lymph nodes and large intestine was observed in RA-SKG mice. P. copri induced high production of IL-6 and IL-23, indicating that P.copri has an ability to enhance Th17-biased immune responses. Mono-colonization of P. copri into germ free SKG mice also showed arthritis.

Conclusion: Prevotella–dominated gut microbiota may contribute to the development of arthritis both in human RA patients and SKG mice.


Disclosure: Y. Maeda, None; M. Matsushita, None; M. Narazaki, None; Y. Saeki, None; A. Kumanogoh, None; K. Takeda, None.

To cite this abstract in AMA style:

Maeda Y, Matsushita M, Narazaki M, Saeki Y, Kumanogoh A, Takeda K. The Analysis of Severity of Arthritis in the Intestinal Microbiota-Humanized Mice [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-analysis-of-severity-of-arthritis-in-the-intestinal-microbiota-humanized-mice/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-analysis-of-severity-of-arthritis-in-the-intestinal-microbiota-humanized-mice/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology